To determine biological subtypes of breast cancer, an immunohistochemical study is carried out where oestrogen and progesterone receptors, HER2 overexpression, or C-ERB B2 oncogen and Ki-67 cell proliferation marker amplifications are indicators of tumour malignancy. This evidence concerns the gene ERBB2 and neoplasm.